Bacillus licheniformis Zhengchangsheng® attenuates DSS-induced colitis and modulates the gut microbiota in mice
In: Beneficial MicrobesSearch for other papers by Y. Li in
Current site
Google Scholar
Search for other papers by M. Liu in
Current site
Google Scholar
Search for other papers by J. Zhou in
Current site
Google Scholar
Search for other papers by B. Hou in
Current site
Google Scholar
Search for other papers by X. Su in
Current site
Google Scholar
Search for other papers by Z. Liu in
Current site
Google Scholar
Search for other papers by J. Yuan in
Current site
Google Scholar
Search for other papers by M. Li in
Current site
Google Scholar
Human inflammatory bowel disease (IBD) and experimental colitis models in mice are associated with shifts in gut microbiota composition, and several probiotics are widely used to improve gastrointestinal health. Here, we investigated whether the probiotic Bacillus licheniformis Zhengchangsheng® (BL) ameliorates dextran sulphate sodium (DSS)-induced colitis through alteration of the gut microbiota. Experimental colitis was induced in BALB/C mice by dissolving 3% DSS in their drinking water for 7 days, which were gavaged with 0.2 ml phosphate-buffered saline or BL (3×107 cfu/ml) once a day. Administration of BL attenuated several effects of DSS-induced colitis, including weight loss, increased disease activity index, and disrupted intestinal barrier integrity. In addition, BL mitigated the reduction in faecal microbiota richness in DSS treated mice. Interestingly, BL was found to reduce the elevated circulating endotoxin level in mice with colitis by modulating the microbial composition of the microbiota, and this was highly associated with a proportional decrease in gut Bacteroidetes. Our results demonstrate that BL can attenuate DSS-induced colitis and provide valuable insight into microbiota interactions during IBD.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
-
Abraham, B.P. and Quigley, E.M.M., 2017. Probiotics in inflammatory bowel disease. Gastroenterology Clinics of North America 46: 769-782.
'Probiotics in inflammatory bowel disease ' () 46 Gastroenterology Clinics of North America : 769 -782 .
-
Amer, M., Nadeem, M., Nazir, S.U.R., Fakhar, M., Abid, F., Ain, Q.U. and Asif, E., 2018. Probiotics and their use in inflammatory bowel disease. Alternative Therapies in Health and Medicine 24: 16-23.
'Probiotics and their use in inflammatory bowel disease ' () 24 Alternative Therapies in Health and Medicine : 16 -23 .
-
Arena, A., Maugeri, T.L., Pavone, B., Iannello, D., Gugliandolo, C. and Bisignano, G., 2006. Antiviral and immunoregulatory effect of a novel exopolysaccharide from a marine thermotolerant Bacillus licheniformis. International Immunopharmacology 6: 8-13.
'Antiviral and immunoregulatory effect of a novel exopolysaccharide from a marine thermotolerant Bacillus licheniformis ' () 6 International Immunopharmacology : 8 -13 .
-
Bábíčková, J., Tóthová, Ľ. and Lengyelová, E., 2015. Sex differences in experimentally induced colitis in mice: a role for estrogens. Inflammation 38: 1996-2006.
'Sex differences in experimentally induced colitis in mice: a role for estrogens ' () 38 Inflammation : 1996 -2006 .
-
Bengmark, S., 2001. Pre-, pro- and synbiotics. Current Opinion in Clinical Nutrition and Metabolic Care 4: 571-579.
'Pre-, pro- and synbiotics ' () 4 Current Opinion in Clinical Nutrition and Metabolic Care : 571 -579 .
-
Bron, P.A., van Baarlen, P. and Kleerebezem, M., 2011. Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nature Reviews Microbiology 10: 66. DOI: https://doi.org/10.1038/nrmicro2690
-
Derrien, M., Collado, M.C., Ben-Amor, K., Salminen, S., De Vos, W.M., 2008. The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Applied and Environmental Microbiology 74: 1646-1648.
'The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract ' () 74 Applied and Environmental Microbiology : 1646 -1648 .
-
Ding, S., Walton, K.L., Blue, R.E., McNaughton, K., Magness, S.T. and Lund, P.K., 2012. Mucosal healing and fibrosis after acute or chronic inflammation in wild type FVB-N mice and C57BL6 procollagen α1(I)-promoter-GFP reporter mice. PLoS ONE 7: e42568.
'Mucosal healing and fibrosis after acute or chronic inflammation in wild type FVB-N mice and C57BL6 procollagen α1(I)-promoter-GFP reporter mice ' () 7 PLoS ONE : e42568 .
-
Dingemanse, C., Belzer, C., Van Hijum, S.A., Günthel, M., Salvatori, D., Den Dunnen, J.T., Kuijper, E.J., Devilee, P., De Vos, W.M., Van Ommen, G.B. and Robanus-Maandag, E.C., 2015. Akkermansia muciniphila and Helicobacter typhlonius modulate intestinal tumor development in mice. Carcinogenesis 36: 1388-1396.
'Akkermansia muciniphila and Helicobacter typhlonius modulate intestinal tumor development in mice ' () 36 Carcinogenesis : 1388 -1396 .
-
Du, S.X., Jia, Y.R., Renm, S.Q., Gong, X.J., Tang, H., Wan-Shui, W. and Li-Ming, S., 2018. The protective effects of Bacillus licheniformis preparation on gastrointestinal disorders and inflammation induced by radiotherapy in pediatric patients with central nervous system tumor. Advances in Medical Sciences 63: 134-139.
'The protective effects of Bacillus licheniformis preparation on gastrointestinal disorders and inflammation induced by radiotherapy in pediatric patients with central nervous system tumor ' () 63 Advances in Medical Sciences : 134 -139 .
-
Fujio-Vejar, S., Vasquez, Y., Morales, P., Magne, F., Vera-Wolf, P., Ugalde, J.A., Navarrete, P., and Gotteland, M., 2017. The gut microbiota of healthy Chilean subjects reveals a high abundance of the Phylum Verrucomicrobia. Frontiers in Microbiology 8: 1221.
'The gut microbiota of healthy Chilean subjects reveals a high abundance of the Phylum Verrucomicrobia ' () 8 Frontiers in Microbiology : 1221 .
-
Furrie, E., Macfarlane, S., Kennedy, A., Cummings, J.H., Walsh, S.V., O’neil, D.A. and Macfarlane, G.T., 2005. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 54: 242-249.
'Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial ' () 54 Gut : 242 -249 .
-
Galvez, J., 2014. Role of Th17 cells in the pathogenesis of human IBD. ISRN Inflammation 2014: 928461.
'Role of Th17 cells in the pathogenesis of human IBD ' () 2014 ISRN Inflammation : 928461 .
-
Ganji-Arjenaki, M. and Rafieian-Kopaei, M., 2018. Probiotics are a good choice in remission of inflammatory bowel diseases: a meta analysis and systematic review. Journal of Cellular Physiology 233: 2091-2103.
'Probiotics are a good choice in remission of inflammatory bowel diseases: a meta analysis and systematic review ' () 233 Journal of Cellular Physiology : 2091 -2103 .
-
Ghosh, S., Van Heel, D. and Playford, R.J., 2004. Probiotics in inflammatory bowel disease: is it all gut flora modulation? Gut 53: 620-622.
'Probiotics in inflammatory bowel disease: is it all gut flora modulation? ' () 53 Gut : 620 -622 .
-
Hegazy, S.K. and El-Bedewy, M.M., 2010. Effect of probiotics on pro-inflammatory cytokines and NF-kappaB activation in ulcerative colitis. World Journal of Gastroenterology 16: 4145-4151.
'Effect of probiotics on pro-inflammatory cytokines and NF-kappaB activation in ulcerative colitis ' () 16 World Journal of Gastroenterology : 4145 -4151 .
-
Hendrickson, B.A., Gokhale, R. and Cho, J.H., 2002. Clinical aspects and pathophysiology of inflammatory bowel disease. Clinical Microbiology Reviews 15: 79-94.
'Clinical aspects and pathophysiology of inflammatory bowel disease ' () 15 Clinical Microbiology Reviews : 79 -94 .
-
Heo, J., Kim, S.K., Park, K.S., Jung, H.K., Kwon, J.G. and Jang, B.I., 2014. A double-blind, randomized, active drug comparative, parallel-group, multi-center clinical study to evaluate the safety and efficacy of probiotics (Bacillus licheniformis, Zhengchangsheng® capsule) in patients with diarrhea. Intestinal Research 12: 236-244.
'A double-blind, randomized, active drug comparative, parallel-group, multi-center clinical study to evaluate the safety and efficacy of probiotics (Bacillus licheniformis, Zhengchangsheng® capsule) in patients with diarrhea ' () 12 Intestinal Research : 236 -244 .
-
Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., Canani, R.B., Flint, H.J., Salminen, S., Calder, P.C. and Sanders, M.E., 2014. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology and Hepatology 11: 506-514.
'Expert consensus document ' () 11 Nature Reviews Gastroenterology and Hepatology : 506 -514 .
-
Ishikawa, H., Matsumoto, S., Ohashi, Y., Imaoka, A., Setoyama, H., Umesaki, Y., Tanaka, R. and Otani, T., 2011. Beneficial effects of probiotic Bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study. Digestion 84: 128-133.
'Beneficial effects of probiotic Bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study ' () 84 Digestion : 128 -133 .
-
Jing, Y., Liu, H., Xu, W. and Yang, Q., 2017. Amelioration of the DSS-induced colitis in mice by pretreatment with 4,4’-diaponeurosporene-producing Bacillus subtilis. Experimental and Therapeutic Medicine 14: 6069-6073.
'Amelioration of the DSS-induced colitis in mice by pretreatment with 4,4’-diaponeurosporene-producing Bacillus subtilis ' () 14 Experimental and Therapeutic Medicine : 6069 -6073 .
-
Kang, C.S., Ban, M., Choi, E.J., Moon, H.G., Jeon, J.S., Kim, D.K., Park, S.K., Jeon, S.G., Roh, T.Y., Myung, S.J., Gho, Y.S., Kim, J.G. and Kim, Y.K., 2013. Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis. PLoS ONE 8: e76520.
'Extracellular vesicles derived from gut microbiota, especially Akkermansia muciniphila, protect the progression of dextran sulfate sodium-induced colitis ' () 8 PLoS ONE : e76520 .
-
Kato, K., Mizuno, S., Umesaki, Y., Ishii, Y., Sugitani, M., Imaoka, A., Otsuka, M., Hasunuma, O., Kurihara, R., Iwasaki, A. and Arakawa, Y., 2004. Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Alimentary Pharmacology and Therapeutics 20: 1133-1141.
'Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis ' () 20 Alimentary Pharmacology and Therapeutics : 1133 -1141 .
-
Ki, Y., Kim, W., Cho, H., Ahn, K., Choi, Y. and Kim, D., 2014. The effect of probiotics for preventing radiation-induced morphological changes in intestinal mucosa of rats. Journal of Korean Medical Science 29: 1372-1378.
'The effect of probiotics for preventing radiation-induced morphological changes in intestinal mucosa of rats ' () 29 Journal of Korean Medical Science : 1372 -1378 .
-
Lee, S.H., 2015. Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases. Intestinal Research 13: 11-18.
'Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases ' () 13 Intestinal Research : 11 -18 .
-
Li, M., Li, Z., Wen, S., Liu, Y., Wang, Y., and Tang, L., 2016. Transplantation of a bacterial consortium ameliorates trinitrobenzenesulfonic acid-induced colitis and intestinal dysbiosis in rats. Future Microbiology 11: 887-902.
'Transplantation of a bacterial consortium ameliorates trinitrobenzenesulfonic acid-induced colitis and intestinal dysbiosis in rats ' () 11 Future Microbiology : 887 -902 .
-
Li, M., Wang, B., Sun, X., Tang, Y., Wei, X., Ge, B., Tang, Y., Deng, Y., He, C., Yuan, J. and Li, X., 2017. Upregulation of intestinal barrier function in mice with DSS-induced colitis by a defined bacterial consortium is associated with expansion of IL-17A producing gamma delta T cells. Frontiers in Immunology 8: 824.
'Upregulation of intestinal barrier function in mice with DSS-induced colitis by a defined bacterial consortium is associated with expansion of IL-17A producing gamma delta T cells ' () 8 Frontiers in Immunology : 824 .
-
Lukiw, W.J., 2016. Bacteroides fragilis lipopolysaccharide and inflammatory signaling in Alzheimer’s disease. Frontiers in Microbiology 7: 1544.
'Bacteroides fragilis lipopolysaccharide and inflammatory signaling in Alzheimer’s disease ' () 7 Frontiers in Microbiology : 1544 .
-
Maloy, K.J. and Powrie, F., 2011. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474: 298-306.
'Intestinal homeostasis and its breakdown in inflammatory bowel disease ' () 474 Nature : 298 -306 .
-
Martín, R., Chain, F., Miquel, S., Motta, J.P., Vergnolle, N., Sokol, H. and Langella, P., 2017. Using murine colitis models to analyze probiotics-host interactions. FEMS Microbiology Reviews 41, Suppl. 1: S49-S70.
'Using murine colitis models to analyze probiotics-host interactions ' () 1 : S49 -S70 .
-
Morgan, X.C., Tickle, T.L., Sokol, H., Gevers, D., Devaney, K.L., Ward, D.V., Reyes, J.A., Shah, S.A., LeLeiko, N., Snapper, S.B., Bousvaros, A., Korzenik, J., Sands, B.E., Xavier, R.J. and Huttenhower, C., 2012. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biology 13: R79.
'Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment ' () 13 Genome Biology : R79 .
-
Nanau, R.M. and Neuman, M.G., 2012. Nutritional and probiotic supplementation in colitis models. Digestive Diseases and Sciences 57: 2786-2810.
'Nutritional and probiotic supplementation in colitis models ' () 57 Digestive Diseases and Sciences : 2786 -2810 .
-
Nell, S., Suerbaum, S. and Josenhans, C., 2010. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nature Reviews Microbiology 8: 564-577.
'The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models ' () 8 Nature Reviews Microbiology : 564 -577 .
-
Ni, J., Wu, G.D., Albenberg, L., Tomov, V.T., 2017. Gut microbiota and IBD: causation or correlation? Nature Reviews Gastroenterology and Hepatology 14: 573-584.
'Gut microbiota and IBD: causation or correlation? ' () 14 Nature Reviews Gastroenterology and Hepatology : 573 -584 .
-
Nithya, V., Muthukumar, S.P. and Halami, P.M., 2012. Safety assessment of Bacillus licheniformis Me1 isolated from milk for probiotic application. International Journal of Toxicology 31: 228-237.
'Safety assessment of Bacillus licheniformis Me1 isolated from milk for probiotic application ' () 31 International Journal of Toxicology : 228 -237 .
-
Park, J.S., Choi, J., Kwon, J.Y., Jung, K.A., Yang, C.W., Park, S.H. and Cho, M.L., 2018. A probiotic complex, rosavin, zinc, and prebiotics ameliorate intestinal inflammation in an acute colitis mouse model. Journal of Translational Medicine 16: 37.
'A probiotic complex, rosavin, zinc, and prebiotics ameliorate intestinal inflammation in an acute colitis mouse model ' () 16 Journal of Translational Medicine : 37 .
-
Png, C.W., Linden, S.K., Gilshenan, K.S., Zoetendal, E.G. McSweeney, C.S., Sly, L.I., McGuckin, M.A., Florin, T.H., 2010. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. American Journal of Gastroenterology 105: 2420-2428.
'Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria ' () 105 American Journal of Gastroenterology : 2420 -2428 .
-
Rajilic-Stojanovic, M., Shanahan, F., Guarner, F., De Vos, W.M., 2013. Phylogenetic analysis of dysbiosis in ulcerative colitis during remission. Inflammatory Bowel Diseases 19: 481-488.
'Phylogenetic analysis of dysbiosis in ulcerative colitis during remission ' () 19 Inflammatory Bowel Diseases : 481 -488 .
-
Redman, M.G., Ward, E.J. and Phillips, R.S., 2014. The efficacy and safety of probiotics in people with cancer: a systematic review. Annals of Oncology 25: 1919-1929.
'The efficacy and safety of probiotics in people with cancer: a systematic review ' () 25 Annals of Oncology : 1919 -1929 .
-
Ren, T., Grants, I., Alhaj, M., McKiernan, M., Jacobson, M., Hassanain, H.H., Frankel, W., Wunderlich, J. and Christofi, F.L., 2011. Impact of disrupting adenosine A3 receptors (A3 -/-AR) on colonic motility or progression of colitis in the mouse. Inflammatory Bowel Diseases 17: 1698-1713.
'Impact of disrupting adenosine A3 receptors (A3 -/-AR) on colonic motility or progression of colitis in the mouse ' () 17 Inflammatory Bowel Diseases : 1698 -1713 .
-
Sartor, R.B., 2004. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126: 1620-1633.
'Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics ' () 126 Gastroenterology : 1620 -1633 .
-
Sartor, R.B., 2008. Microbial influences in inflammatory bowel diseases. Gastroenterology 134: 577-594.
'Microbial influences in inflammatory bowel diseases ' () 134 Gastroenterology : 577 -594 .
-
Shi, Y., Zhao, X., Jianxin, Z., Zhang, H., Zhai, Q., Narbad, A. and Chen, W., 2018. A mixture of Lactobacillus species isolated from traditional fermented foods promote recovery from antibiotic-induced intestinal disruption in mice. Journal of Applied Microbiology 124: 842-854.
'A mixture of Lactobacillus species isolated from traditional fermented foods promote recovery from antibiotic-induced intestinal disruption in mice ' () 124 Journal of Applied Microbiology : 842 -854 .
-
Timko, J., 2013. Effect of probiotics on the fecal microflora after radiotherapy: a pilot study. Indian Journal of Pathology & Microbiology 56: 31-35.
'Effect of probiotics on the fecal microflora after radiotherapy: a pilot study ' () 56 Indian Journal of Pathology & Microbiology : 31 -35 .
-
Turner, J.R., 2009. Intestinal mucosal barrier function in health and disease. Nature Reviews Immunology 9: 799-809.
'Intestinal mucosal barrier function in health and disease ' () 9 Nature Reviews Immunology : 799 -809 .
-
Walker, A.W., Sanderson, J.D., Churcher, C., Churcher, C., Parkes, G.C., Hudspith, B.N., Rayment, N., Brostoff, J., Parkhill, J., Dougan. G. and Petrovska, L., 2011. High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbiology 11: 7.
'High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease ' () 11 BMC Microbiology : 7 .
-
Wallace, B.D., Wang, H., Lane, K.T., Scott, J.E., Orans, J., Koo, J.S., Venkatesh, M., Jobin, C., Yeh, L.A., Mani, S. and Redinbo, M.R., 2010. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 330: 831-835.
'Alleviating cancer drug toxicity by inhibiting a bacterial enzyme ' () 330 Science : 831 -835 .
-
Wells, C.L., Van de Westerlo, E.M., Jechorek, R.P., Feltis, B.A., Wilkins, T.D. and Erlandsen, S.L., 1996. Bacteroides fragilis enterotoxin modulates epithelial permeability and bacterial internalization by HT-29 enterocytes. Gastroenterology 110: 1429-1437.
'Bacteroides fragilis enterotoxin modulates epithelial permeability and bacterial internalization by HT-29 enterocytes ' () 110 Gastroenterology : 1429 -1437 .
-
Zhang, X., Deeke, S.A., Ning, Z., Starr, A.E., Butcher, J., Li, J., Mayne, J., Cheng, K., Liao, B., Li, L., Singleton, R., Mack, D., Stintzi, A. and Figeys, D., 2018. Metaproteomics reveals associations between microbiome and intestinal extracellular vesicle proteins in pediatric inflammatory bowel disease. Nature Communications 9: 2873.
'Metaproteomics reveals associations between microbiome and intestinal extracellular vesicle proteins in pediatric inflammatory bowel disease ' () 9 Nature Communications : 2873 .
Supplementary Materials
| All Time | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 31 | 31 | 9 |
| Full Text Views | 8 | 8 | 0 |
| PDF Views & Downloads | 5 | 5 | 1 |
Bacillus licheniformis Zhengchangsheng® attenuates DSS-induced colitis and modulates the gut microbiota in mice
In: Beneficial MicrobesSearch for other papers by Y. Li in
Current site
Google Scholar
PubMed
Search for other papers by M. Liu in
Current site
Google Scholar
PubMed
Search for other papers by J. Zhou in
Current site
Google Scholar
PubMed
Search for other papers by B. Hou in
Current site
Google Scholar
PubMed
Search for other papers by X. Su in
Current site
Google Scholar
PubMed
Search for other papers by Z. Liu in
Current site
Google Scholar
PubMed
Search for other papers by J. Yuan in
Current site
Google Scholar
PubMed
Search for other papers by M. Li in
Current site
Google Scholar
PubMed
Human inflammatory bowel disease (IBD) and experimental colitis models in mice are associated with shifts in gut microbiota composition, and several probiotics are widely used to improve gastrointestinal health. Here, we investigated whether the probiotic Bacillus licheniformis Zhengchangsheng® (BL) ameliorates dextran sulphate sodium (DSS)-induced colitis through alteration of the gut microbiota. Experimental colitis was induced in BALB/C mice by dissolving 3% DSS in their drinking water for 7 days, which were gavaged with 0.2 ml phosphate-buffered saline or BL (3×107 cfu/ml) once a day. Administration of BL attenuated several effects of DSS-induced colitis, including weight loss, increased disease activity index, and disrupted intestinal barrier integrity. In addition, BL mitigated the reduction in faecal microbiota richness in DSS treated mice. Interestingly, BL was found to reduce the elevated circulating endotoxin level in mice with colitis by modulating the microbial composition of the microbiota, and this was highly associated with a proportional decrease in gut Bacteroidetes. Our results demonstrate that BL can attenuate DSS-induced colitis and provide valuable insight into microbiota interactions during IBD.
| All Time | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 31 | 31 | 9 |
| Full Text Views | 8 | 8 | 0 |
| PDF Views & Downloads | 5 | 5 | 1 |